Works across CT and CMR to develop and validate quantitative imaging biomarkers. Integrates AI with advanced acquisition to study cardio‑pulmonary and brain–heart interactions, and builds population‑based reference ranges and risk models using large cohorts (e.g., MESA, UK Biobank).